KRAS and cancer: Additionally, because different K-Ras mutations have distinct transforming potential and preferentially activate different effector pathways, it would be relevant to understand whether they impact the interaction between cancer cells and the microenvironment differently and which signaling pathways have a prevalent role in each process.